Sanofi-Aventis to Market HIV Treatment

Montreal drug researcher Theratechnologies Inc. signed a key licensing pact with the European-based multinational Sanofi-Aventis SA covering marketing of its tesamorelin product in Latin America, Africa and the Mid-east.
Montreal Gazette